BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34060027)

  • 1. The role of MRI in cervical cancer > 2 cm (FIGO stage IB2-IIA1) conservatively treated with neoadjuvant chemotherapy followed by conization: a pilot study.
    Russo L; Gui B; Miccò M; Panico C; De Vincenzo R; Fanfani F; Scambia G; Manfredi R
    Radiol Med; 2021 Aug; 126(8):1055-1063. PubMed ID: 34060027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy followed by conization in stage IB2-IIA1 cervical cancer larger than 2 cm: a pilot study.
    de Vincenzo R; Ricci C; Fanfani F; Gui B; Gallotta V; Fagotti A; Ferrandina G; Scambia G
    Fertil Steril; 2021 Jan; 115(1):148-156. PubMed ID: 33092819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer ≥2 cm.
    Rendón GJ; Lopez Blanco A; Aragona A; Saadi JM; Di Guilmi J; Arab Eblen C; Heredia Muñoz F; Pareja R
    Int J Gynecol Cancer; 2021 Mar; 31(3):462-467. PubMed ID: 33199429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
    Salihi R; Leunen K; Van Limbergen E; Moerman P; Neven P; Vergote I
    Gynecol Oncol; 2015 Dec; 139(3):447-51. PubMed ID: 26050921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives.
    Gwacham NI; McKenzie ND; Fitzgerald ER; Ahmad S; Holloway RW
    Gynecol Oncol; 2021 Sep; 162(3):809-815. PubMed ID: 34130862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer.
    Zusterzeel PLM; Aarts JWM; Pol FJM; Ottevanger PB; van Ham MAPC
    Oncologist; 2020 Jul; 25(7):e1051-e1059. PubMed ID: 32339376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.
    Plante M; van Trommel N; Lheureux S; Oza AM; Wang L; Sikorska K; Ferguson SE; Han K; Amant F
    Int J Gynecol Cancer; 2019 Jun; 29(5):969-975. PubMed ID: 31101688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer.
    Salihi R; Leunen K; Moerman P; Amant F; Neven P; Vergote I
    Int J Gynecol Cancer; 2017 Jul; 27(6):1256-1260. PubMed ID: 28574931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy and vaginal radical trachelectomy for fertility-sparing treatment in women affected by cervical cancer (FIGO stage IB-IIA1).
    Marchiole P; Tigaud JD; Costantini S; Mammoliti S; Buenerd A; Moran E; Mathevet P
    Gynecol Oncol; 2011 Sep; 122(3):484-90. PubMed ID: 21636113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning applied to MRI evaluation for the detection of lymph node metastasis in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy.
    Arezzo F; Cormio G; Mongelli M; Cazzato G; Silvestris E; Kardhashi A; Cazzolla A; Lombardi C; Venerito V; Loizzi V
    Arch Gynecol Obstet; 2023 Jun; 307(6):1911-1919. PubMed ID: 36370209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy.
    Tesfai FM; Kroep JR; Gaarenstroom K; De Kroon C; Van Loenhout R; Smit V; Trimbos B; Nout RA; van Poelgeest MIE; Beltman JJ
    Int J Gynecol Cancer; 2020 Jan; 30(1):115-121. PubMed ID: 31744889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREATMENT OPTION TO THE FERTILITY-SPARING RADICAL TRACHELECTOMY AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH CERVICAL CANCER WITH TUMOR SIZE >2CM.
    Shipko A; Renkas O; Svintsitskyi V; Pryimak V; Movchan O
    Exp Oncol; 2022 Nov; 44(3):254-258. PubMed ID: 36325709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.
    Maneo A; Chiari S; Bonazzi C; Mangioni C
    Gynecol Oncol; 2008 Dec; 111(3):438-43. PubMed ID: 18835493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy in early-stage cervical cancer (<2 cm) before conization for fertility preservation: is there any advantage over upfront conization?
    Noll F; Palacios Torres AT; Pecci P; Lucchini SM; Heredia F
    Int J Gynecol Cancer; 2021 Mar; 31(3):379-386. PubMed ID: 33649005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal radical trachelectomy versus chemotherapy followed by vaginal radical trachelectomy in stage 1B2 (FIGO 2018) cervical cancer. A systematic review on fertility and recurrence rates.
    van Kol KGG; Vergeldt TFM; Bekkers RLM
    Gynecol Oncol; 2019 Dec; 155(3):515-521. PubMed ID: 31606284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of less radical fertility-sparing procedures with omitted parametrectomy for cervical cancer: 5years of experience.
    Slama J; Cerny A; Dusek L; Fischerova D; Zikan M; Kocian R; Germanova A; Cibula D
    Gynecol Oncol; 2016 Sep; 142(3):401-4. PubMed ID: 27396943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Parametrial Status in Locally Advanced Cervical Cancer Patients after Neoadjuvant Chemotherapy: A Prospective Study on Diagnostic Accuracy of Three-Dimensional Transvaginal Ultrasound.
    Perniola G; Fischetti M; Tomao F; Di Donato V; Palaia I; Santangelo G; Lecce F; Piccioni MG; Muzii L; Benedetti Panici P
    Oncology; 2020; 98(9):603-611. PubMed ID: 32492692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy followed by radical trachelectomy versus upfront abdominal radical trachelectomy for patients with FIGO 2018 stage IB2 cervical cancer.
    Li X; Jiang Z; Lu J; Chen X; Ge H; Wu X; Li J
    Gynecol Oncol; 2023 Feb; 169():106-112. PubMed ID: 36543029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of cold knife conization as conservative management in patients with microinvasive cervical squamous cell cancer (stage IA1).
    He Y; Wu YM; Zhao Q; Wang T; Wang Y; Kong WM; Song F; Duan W; Zhu L; Zhang WY
    Int J Gynecol Cancer; 2014 Sep; 24(7):1306-11. PubMed ID: 24987910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.